Loading company…
Develops a neuromodulation device for managing postoperative pain after knee surgery.
Synaptrix develops NOVABLOC, an investigational neuromodulation device intended to provide drug-free pain relief after knee surgery. It is designed to target nerves that transmit pain signals from the surgical site. Founded in 2023, the company is based in Alpharetta, US. In November 2024, it raised USD 10 million in series A funding led by Hatteras Venture Partners, Rex Health Ventures, Avanos Medical, Inc., and Portal Innovations.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in